Attovia Therapeutics

BiotechnologySeries CSan Carlos, USattovia.com

Latest round

Series C

Last raised

Apr 2025

Total raised

$173M

Investors

14

About Attovia Therapeutics

Founded in 2023 and based in California, US, Attovia Therapeutics, Inc. operates as a biotechnology company that develops biotherapeutics for the treatment of immune-mediated disease and cancer. Attovia is focused on creating a pipeline of biotherapeutics in immune-mediated disease and oncology. The company leverages Attobody™, Alamar Biosciences’ novel biparatopic nanobody platform, to generate small format binders with low picomolar affinity, enhanced specificity, accelerated internalization, and fast tissue penetration. Attovia’s lead program is an Attobody to treat immune disease. The company is currently progressing multiple programs and plans to initiate additional discovery projects.

Who invested in Attovia Therapeutics

14 investors across 3 rounds

See all investors in Attovia Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Apr 15, 2025

    Amount

    $90M

    Investors

    Locked

  2. Series B

    May 1, 2024

    Amount

    $53M

    Investors

    Locked

  3. Series A

    Jun 1, 2023

    Amount

    $30M

    Investors

    Locked

Questions about Attovia Therapeutics

Who invested in Attovia Therapeutics?

Attovia Therapeutics has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Attovia Therapeutics raised?

Attovia Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Attovia Therapeutics last raise money?

Attovia Therapeutics's most recent round on record is a Series C, in Apr 2025.

What does Attovia Therapeutics do?

Founded in 2023 and based in California, US, Attovia Therapeutics, Inc.

Where is Attovia Therapeutics headquartered?

Attovia Therapeutics is headquartered in San Carlos, US.

Which VCs invest in companies like Attovia Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Attovia Therapeutics's stage. Their profiles are linked below.

Raising like Attovia Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.